Harmony Biosciences Holdings (HRMY) Research & Development (2019 - 2025)
Historic Research & Development for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $55.0 million.
- Harmony Biosciences Holdings' Research & Development rose 11649.66% to $55.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.3 million, marking a year-over-year increase of 2322.98%. This contributed to the annual value of $145.8 million for FY2024, which is 9171.61% up from last year.
- As of Q3 2025, Harmony Biosciences Holdings' Research & Development stood at $55.0 million, which was up 11649.66% from $50.2 million recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Research & Development ranged from a high of $63.6 million in Q2 2024 and a low of $4.7 million during Q1 2021
- Moreover, its 5-year median value for Research & Development was $17.5 million (2023), whereas its average is $24.4 million.
- Its Research & Development has fluctuated over the past 5 years, first crashed by 5684.37% in 2023, then skyrocketed by 32476.45% in 2024.
- Harmony Biosciences Holdings' Research & Development (Quarter) stood at $7.5 million in 2021, then surged by 35.44% to $10.1 million in 2022, then skyrocketed by 200.3% to $30.3 million in 2023, then increased by 14.39% to $34.7 million in 2024, then soared by 58.55% to $55.0 million in 2025.
- Its Research & Development was $55.0 million in Q3 2025, compared to $50.2 million in Q2 2025 and $34.5 million in Q1 2025.